Erasca, Inc.
Erasca, Inc.（ERAS）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ERAS · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
3
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Erasca, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ERAS 季度内部人买卖趋势
ERAS 内幕交易卖出 · ERAS 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ERAS CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ERAS 高管卖出股份 · ERAS 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 1, 2026 | Garner Ebun Chief Legal Officer | Option | 80,000 | $136K | Form 4 |
| Apr 1, 2026 | Garner Ebun Chief Legal Officer | Sale | 80,000 | $1.31M⚡ | Form 4 |
| Mar 4, 2026 | Morris Shannon Chief Medical Officer | Option | 20,000 | $34K | Form 4 |
| Mar 4, 2026 | Morris Shannon Chief Medical Officer | Sale | 20,000 | $301K | Form 4 |
| Dec 15, 2025 | Chacko David M. CFO and CBO | Other | 17,793 | $21K | Form 4 |
| Jan 7, 2026 | Garner Ebun General Counsel & Corp. Sec. | Option | 120,000 | $204K | Form 4 |
| Jan 7, 2026 | Garner Ebun General Counsel & Corp. Sec. | Sale | 120,000 | $671K | Form 4 |
| Dec 15, 2025 | Garner Ebun General Counsel & Corp. Sec. | Award | 3,902 | $5K | Form 4 |
| Dec 13, 2024 | Chacko David M. CFO and CBO | Other | 12,324 | $19K | Form 4 |
| Dec 13, 2024 | Garner Ebun General Counsel & Corp. Sec. | Other | 5,731 | $9K | Form 4 |
| May 21, 2024 | Casdin Alexander W. Director | Purchase | 80,000 | $182K | Form 4 |
| Dec 15, 2023 | Chacko David M. CFO and CBO | Other | 7,478 | $12K | Form 4 |
| Dec 15, 2023 | Garner Ebun General Counsel & Corp. Sec. | Other | 5,448 | $9K | Form 4 |
| Dec 6, 2023 | Start Valerie Denise Harding Director | Purchase | 10,000 | $18K | Form 4 |
| Dec 6, 2023 | Lim Jonathan E Chairman & CEO · Director | Purchase | 278,150 | $478K | Form 4 |
| Dec 5, 2023 | Lim Jonathan E Chairman & CEO · Director | Purchase | 721,850 | $1.22M⚡ | Form 4 |
| Dec 4, 2023 | Casdin Alexander W. Director | Purchase | 30,000 | $50K | Form 4 |
| Oct 5, 2023 | Lim Jonathan E Chairman & CEO · Director | Purchase | 1,000,000 | $2.03M⚡ | Form 4 |
| Jun 8, 2023 | Lim Jonathan E Chairman & CEO · Director | Purchase | 100,000 | $275K | Form 4 |
| Apr 10, 2023 | Casdin Alexander W. Director | Purchase | 20,000 | $55K | Form 4 |
| Mar 28, 2023 | Lim Jonathan E Chairman & CEO · Director | Purchase | 100,000 | $284K | Form 4 |
| Feb 1, 2023 | Chacko David M. CFO | Other | 1,748 | $7K | Form 4 |
| Feb 1, 2023 | Chacko David M. CFO | Other | 2 | $8 | Form 4 |
| Feb 1, 2023 | Wei Lin Chief Medical Officer | Other | 1,748 | $7K | Form 4 |
| Feb 1, 2023 | Wei Lin Chief Medical Officer | Other | 2 | $8 | Form 4 |
Lim Jonathan E
Chairman & CEO · Director
日期
Dec 6
股数
278,150
均价
$1.72
总金额
$478K
Lim Jonathan E
Chairman & CEO · Director
日期
Dec 5
股数
721,850
均价
$1.69
总金额
$1.22M ⚡
Lim Jonathan E
Chairman & CEO · Director
日期
Oct 5
股数
1,000,000
均价
$2.03
总金额
$2.03M ⚡
Lim Jonathan E
Chairman & CEO · Director
日期
Jun 8
股数
100,000
均价
$2.75
总金额
$275K
Lim Jonathan E
Chairman & CEO · Director
日期
Mar 28
股数
100,000
均价
$2.84
总金额
$284K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ERAS 内幕交易
ERAS 内幕交易
Erasca, Inc.（ERAS）内幕交易数据来源于公司内部人（包括Garner Ebun (Chief Legal Officer), Morris Shannon (Chief Medical Officer), Chacko David M. (CFO and CBO)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。ERAS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Erasca, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ERAS 内幕交易 · 5个问题Erasca, Inc.（ERAS）的内部人包括高管和董事，如Garner Ebun (Chief Legal Officer), Morris Shannon (Chief Medical Officer), Chacko David M. (CFO and CBO)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026